Have you been diagnosed with Chronic Pancreatitis? We are currently working on a research study using an Investigational drug that is being evaluated to treat patients who have been diagnosed with Chronic Pancreatitis (CP). The purpose of this study (double‐blind phase) is to determine how well the Investigational drug works in controlling pain associated with this disease; determine the pharmacokinetics (PK) (drug levels of the Investigational drug); and how safe the drug is when taking three doses of NI‐03 (100 mg, 200 mg and 300 mg) when taken three times daily for 28 consecutive days (4 weeks) compared to placebo (sugar pill) also taken in the same manner.
Chronic Pancreatitis clinical trial now enrolling near you. See if you qualify today.
ClinicalTrials.gov Study Details
A phase 1, single dose pk and safety study with NI-03 followed by a phase 2, randomized, double-blind, parallel-group dose-ranging study to evaluated the safety and efficacy of NI-03 compared to placebo in subjects and efficacy of NI-03 compared to placebo in subjects with chronic pancreatitis